Successful Treatment of Central Nervous System Vasculitis Associated with Relapsing Polychondritis With Cyclophosphamide

Am J Med Sci. 2017 May;353(5):495-497. doi: 10.1016/j.amjms.2016.11.023. Epub 2016 Nov 18.

Authors

Maha Almackenzie¹, Ahmad Alharbi¹, Sharifa Alhassan¹, Eleanor Cook², Nezam Altorok³

Affiliations

¹ Division of Rheumatology and Immunology, Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio.
² Department of Pathology, University of Toledo Medical Center, Toledo, Ohio.
³ Division of Rheumatology and Immunology, Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio. Electronic address: Nezam.Altorok@utoledo.edu.

PMID: 28502337
DOI: 10.1016/j.amjms.2016.11.023

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / administration & dosage
Adult
Cyclophosphamide / therapeutic use*
Ear / pathology
Humans
Immunosuppressive Agents / therapeutic use
Inflammation
Male
Methylprednisolone / administration & dosage
Polychondritis, Relapsing / complications
Polychondritis, Relapsing / therapy*
Treatment Outcome
Vasculitis, Central Nervous System / complications
Vasculitis, Central Nervous System / therapy*

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Cyclophosphamide
Methylprednisolone